MDXG logo

MDXG
Mimedx Group Inc

4,781
Mkt Cap
$1.1B
Volume
735,666.00
52W High
$10.14
52W Low
$5.79
PE Ratio
27.03
MDXG Fundamentals
Price
$7.28
Prev Close
$7.47
Open
$7.50
50D MA
$7.07
Beta
0.95
Avg. Volume
948,833.35
EPS (Annual)
$0.2846
P/B
4.57
Rev/Employee
$416,820.79
Loading...
Loading...
News
all
press releases
Kimberly Maersk-Moller Sells 58,300 Shares of MiMedx Group (NASDAQ:MDXG) Stock
MiMedx Group, Inc (NASDAQ:MDXG - Get Free Report) insider Kimberly Maersk-Moller sold 58,300 shares of the firm's stock in a transaction that occurred on Thursday, November 6th. The shares were sold...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
FY2026 EPS Estimates for MiMedx Group Reduced by Analyst
MiMedx Group, Inc (NASDAQ:MDXG - Free Report) - Stock analysts at Northland Capmk decreased their FY2026 EPS estimates for shares of MiMedx Group in a note issued to investors on Monday, November...
MarketBeat·9d ago
News Placeholder
Wall Street Analysts Predict a 64.86% Upside in MiMedx (MDXG): Here's What You Should Know
The mean of analysts' price targets for MiMedx (MDXG) points to a 64.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Zacks·15d ago
News Placeholder
MiMedx (MDXG) Tops Q3 Earnings and Revenue Estimates
MiMedx (MDXG) delivered earnings and revenue surprises of +114.29% and +19.99%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·17d ago
News Placeholder
MiMedx (MDXG) Q2 Earnings and Revenues Beat Estimates
MiMedx (MDXG) delivered earnings and revenue surprises of +66.67% and +10.45%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
MiMedx and Organogenesis stocks tumble after CMS proposal to slash spending
Investing.com -- MiMedx Group (NASDAQ:MDXG) stock fell 19% and Organogenesis Holdings (NASDAQ:ORGO) shares plunged 36% after the Centers for Medicare&Medicaid Services (CMS) proposed a rule that would drastically cut Medicare spending on skin substitutes.
investing.com·4mo ago
News Placeholder
Strength Seen in MiMedx (MDXG): Can Its 8.0% Jump Turn into More Strength?
MiMedx (MDXG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks·4mo ago
News Placeholder
EX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE PRODUCTS"
EX-MiMEDX EMPLOYEES ALLEGE MiMEDX 'PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE...
PR Newswire·1y ago
News Placeholder
THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES'
THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES' THIRD DEFENDANT FIGHTS BACK AGAINST MiMEDX, CLAIMING 'DISREPUTABLE AND UNLAWFUL BUSINESS PRACTICES...
PR Newswire·1y ago
News Placeholder
DEFENDANT FIGHTS BACK AGAINST MiMEDX "BLATANT INTIMIDATION" NON-COMPETE SUIT
DEFENDANT FIGHTS BACK AGAINST MiMEDX 'BLATANT INTIMIDATION' NON-COMPETE SUIT DEFENDANT FIGHTS BACK AGAINST MiMEDX 'BLATANT INTIMIDATION' NON-COMPETE SUIT PR Newswire MARIETTA, Ga., Aug. 26, 2024...
PR Newswire·1y ago

Latest MDXG News

View

Advertisement|Remove ads.

Advertisement|Remove ads.